Charles River Laboratories CRL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$182.84M— | -$142.16M— | —— | —— | —— | ||
| $350.1M-11.8% | $403.31M+11.5% | $427.14M+25.6% | $430.17M+30.0% | $396.75M+23.1% | ||
| $80.33M+21.2% | $71.08M+1.7% | $70.69M-2.1% | $66.75M-11.8% | $66.29M-12.0% | ||
| —— | —— | —— | -$95.39M-101% | -$85.48M-112% | ||
| $170.29M-22.6% | $165M-23.3% | $233.85M+2,738% | $231.95M+6,009% | $220.14M+4,478% | ||
| —— | —— | —— | —— | —— | ||
| $4.1M-74.3% | $6.06M-59.0% | $11.11M-27.9% | $12.25M-6.5% | $15.94M+0.7% | ||
| $229K+102% | -$35.74M-65.4% | -$11.42M— | -$2.05M— | -$9.54M— | ||
| —— | —— | —— | —— | $10.68M-77.8% | ||
| —— | —— | —— | —— | —— | ||
| -$17.15M— | $81.87M— | $56.25M— | —— | —— | ||
| —— | —— | $78.04M— | —— | —— | ||
| -$31.73M— | -$38.14M— | -$7.36M— | $21.7M— | —— | ||
| $607.03M-21.8% | $737.65M+0.4% | $749.49M-5.9% | $787.45M+5.0% | $776.39M+10.2% | ||
| $215.74M+1.2% | $219.15M-5.9% | $205.82M-12.7% | $208.96M-20.5% | $213.15M-26.7% | ||
| $405.01M— | $0— | —— | —— | —— | ||
| $23.27M-47.5% | $20.08M-62.0% | $20.16M-68.1% | $25.43M-62.1% | $44.31M-20.2% | ||
| —— | —— | —— | —— | $17.44M— | ||
| -$571.69M-179% | -$209.32M+14.6% | -$192.62M+52.7% | -$180.25M+61.3% | -$204.77M+57.4% | ||
| $215.83M-53.4% | $360.67M+203% | $360.7M+203% | $461.39M+2,402% | $462.96M+3,094% | ||
| $1.72B+44.0% | $1.23B+13.5% | $1.18B-17.2% | $1.3B+5.5% | $1.2B+35.3% | ||
| $1.56B+15.2% | $1.35B-9.7% | $1.32B-19.5% | $1.39B-8.4% | $1.35B+36.9% | ||
| $1.94M-18.4% | $714K-97.0% | $771K-97.3% | $1.55M-95.2% | $2.37M-93.3% | ||
| -$83.68M+87.6% | -$536.73M+2.6% | -$560.74M— | -$615.66M— | -$674.6M— | ||
| —— | —— | —— | —— | —— | ||
| -$33.53M— | $10.43M— | -$2.42M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $264.37M+364% | $259.08M+400% | $70.67M+114% | $68.78M+50.5% | $56.97M+54.4% | ||
| —— | —— | —— | —— | —— | ||
| -$17.15M— | $81.87M— | $56.25M— | —— | —— | ||
| $7.54M-82.6% | $12.81M-66.7% | $38.07M+192% | $46.14M+606% | $43.44M+568% | ||
| —— | —— | —— | —— | -$37.43M— | ||
| $4.1M-74.3% | $6.06M-59.0% | $11.11M-27.9% | $12.25M-6.5% | $15.94M+0.7% | ||
| —— | —— | —— | —— | —— | ||
| -$1.8M+63.5% | -$3.36M+26.0% | -$8.06M-1,426% | -$5.27M-428% | -$4.94M-405% | ||
| -$16.02M+45.2% | -$14.02M+55.4% | -$17.23M+36.0% | -$24.47M-39.2% | -$29.23M-360% | ||
| $1.56B+15.2% | $1.35B-9.7% | $1.32B-19.5% | $1.39B-8.4% | $1.35B+36.9% | ||
| $391.29M-30.5% | $518.49M+3.4% | $543.67M-3.0% | $578.5M+18.8% | $563.24M+36.2% | ||
| $391.29M-30.5% | $518.49M+3.4% | $543.67M-3.0% | $578.5M+18.8% | $563.24M+36.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $607.0M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $215.7M of capital expenditures, Charles River Laboratories's free cash flow was $391.3M over the trailing twelve months, down 30.5% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
